Stem cell injection trial to prevent brittle bone disease

Sweden's Karolinska Institute, in collaboration with several hospitals and pharmaceutical companies, will conduct the first trial directly injecting stem cells into fetuses at risk of brittle bone disease early next year.

Illustration photo. (Source: imgur.com).

Stem cells are germ cells or foundation cells that help create all other cells in the human body, ensuring the comprehensive functioning of organs in the body such as the brain, heart, kidneys...

According to researchers, stem cell injections will help strengthen the immature bone structure that can be damaged in the fetus before birth.

In the near future, scientists will test injecting 15 fetuses and another group of 15 newborns with stem cells that can increase the secretion of collagen cartilage - an important protein for strong bones.

According to expert Cecilia Gotherstrom of the Karolinska Institute, a small number of children with brittle bone disease have previously undergone stem cell transplant trials.

One-third of six-year-olds with the condition have also been treated by researchers in Singapore and Taiwan.

All have shown positive results, resulting in a significant reduction in fractures. However, stem cell transplants often do not have a long-term effect on the elderly.

Children with brittle bone disease often face bone fractures, leading to disability and even the risk of premature death.

In addition, malformed rib cages also cause chipped and discolored teeth, hearing loss and breathing difficulties, for which there is currently no cure.

According to statistics, on average, one in every 25,000 Europeans will have brittle bone disease due to a genetic deficiency that secretes collagen cartilage fluid.

If successful, this experiment will open up a ray of hope to reduce brittle bone disease in children right from the womb, helping children have a healthier future./.

According to VIETNAM+